COSCIENS Biopharma Inc. (LON:0UGB)
4.200
-0.050 (-1.18%)
At close: Jan 22, 2025
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of 5.98 million as of September 18, 2025. Its market cap has decreased by -63.41% in one year.
Market Cap
5.98M
Enterprise Value
850.18K
Revenue
6.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.20
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 7.20B to 5.98M, a decrease of -99.92%. That is a compound annual growth rate of -21.42%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 6.11M | 59.00% |
Dec 31, 2024 | 3.84M | -48.21% |
Dec 29, 2023 | 7.42M | -42.06% |
Dec 30, 2022 | 12.80M | -60.28% |
Dec 31, 2021 | 32.23M | 65.68% |
Dec 31, 2020 | 19.46M | 40.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 177.00B |
HSBC Holdings | 174.75B |
Shell | 153.13B |
Unilever | 114.20B |
Rolls-Royce Holdings | 96.19B |
British American Tobacco p.l.c. | 90.16B |
Rio Tinto Group | 79.62B |
BP p.l.c. | 64.73B |